SKI Market

A+| A| A-|

Indian Indices

Sensex

77,269.40 355.90
( 0.46%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Piramal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543635

INE0DK501011

61.2618363

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PPLPHARMA

27.82

21520.53

EPS(TTM)

Face Value()

Div & Yield %

5.82

Back

B C C Fuba India standalone net profit rises 18.18% in the December 2025 quarter

Feb 14,2026

Net profit of B C C Fuba India rose 18.18% to Rs 1.17 crore in the quarter ended December 2025 as against Rs 0.99 crore during the previous quarter ended December 2024. Sales rose 29.03% to Rs 17.29 crore in the quarter ended December 2025 as against Rs 13.40 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	17.29	13.40	29
OPM %	14.11	16.27	-
PBDT	2.11	1.97	7
PBT	1.67	1.72	-3
NP	1.17	0.99	18

77,269.40 355.90 ( 0.46%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)